Under the Clinical Trial Regulation, Auxiliary Medicines have been categorized as Authorised and Unauthorised, and there are requirements that go along with each. What does the Regulation have to say about Auxiliary Medicines and how does that impact sponsors and how these are sourced and labelled? We also invite attendees to share different strategies they have used under the CTR for auxiliary medicines.